Please assess the completion status of the following clinical trial:

Trial Title: Near-infrared Fluorescence Imaging as a Supportive Tool for Localisation of Deep Infiltrating Endometriosis During Laparoscopy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Suspected endometriosis with necessity for laparoscopic confirmation and resection~* Regular menstrual cycles~Exclusion Criteria:~* Patients younger than 18 years and older than 50 years at time of operation~* Subject with previous history of adverse reaction or allergy to Indocyanine Green, iodine, shellfish or iodine dyes~* Documented allergy to sulfur containing compounds~* History of allergic reactions attributed to compounds of similar chemical or biologic composition to Indocyanine Green~* Subject has significant liver disease, cirrhosis or liver insufficiency with abnormal liver function tests (Total bilirubin increased by factor 1.5 than normal and/or serum glutamic oxaloacetic transaminase increased by factor 2 than normal)~* Subject has uremia, serum creatinine (\> 2.0 mg/dl)~* Subject has severe coronary heart disease (instable angina pectoris)~* Pregnant or breast-feeding women~* Subject actively participating in another drug, biologic and/or device protocol~* The presence of medical conditions contraindicating general anesthesia or standard surgical approaches~* Subject has any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Indocyanine Green arm (Type: EXPERIMENTAL): All the enrolled patients met the inclusion criteria. No patients have been excluded from the study. All patient have been subjected, during laparoscopy, to an accurate inspection of the abdomen and all the visible endometriotic lesions have been described. Subsequently, 0.25 mg /(kg BW) Indocyanine Green were administered intravenously during surgery and a second look of the abdomen and pelvis with the Near Infrared Vision has been made, in order to identify the fluorescent lesions. All the lesions has been described and localized pre and post the Indocyanine Green injection and then removed and properly cataloged

Based on this trial design, predict the completion outcome and termination type (if applicable).